In the last 12 months, insiders at 89bio, Inc. ($ETNB) filed 312 transactions with the SEC: 14 open-market purchases totaling $112,103,218 and 20 sales totaling $3,347,476. Net insider sentiment: net buying.
89bio, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- RA CAPITAL MANAGEMENT, L.P. (Not found) — 18 transactions totaling $78,222,499
- RA CAPITAL MANAGEMENT, L.P. (Director) — 2 transactions totaling $40,000,002
- PALEKAR ROHAN (Chief Executive Officer) — 47 transactions totaling $4,075,415
- Le-Nguyen Quoc (See Remarks) — 59 transactions totaling $1,831,518
- Martins Ryan (Chief Financial Officer) — 52 transactions totaling $1,238,332
View all SEC Filings for 89bio, Inc. (ETNB).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 30, 2025 | RA CAPITAL MANAGEMENT, L.P. | Not found | D | Common Stock | 19554319 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 12.39% |
| Oct. 30, 2025 | RA CAPITAL MANAGEMENT, L.P. | Not found | D | Common Stock | 335364 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.21% |
| Oct. 30, 2025 | RA CAPITAL MANAGEMENT, L.P. | Not found | D | Pre-Funded Warrants (Right to Buy) | 4331081 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 2.74% |
| Oct. 30, 2025 | RA CAPITAL MANAGEMENT, L.P. | Not found | D | Stock Option (Right to Buy) | 7000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.00% |
| Oct. 30, 2025 | RA CAPITAL MANAGEMENT, L.P. | Not found | D | Stock Option (Right to Buy) | 7000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.00% |
| Oct. 30, 2025 | RA CAPITAL MANAGEMENT, L.P. | Not found | D | Stock Option (Right to Buy) | 12500 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.01% |
| Oct. 30, 2025 | RA CAPITAL MANAGEMENT, L.P. | Not found | D | Stock Option (Right to Buy) | 25000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.02% |
| Oct. 30, 2025 | RA CAPITAL MANAGEMENT, L.P. | Not found | D | Stock Option (Right to Buy) | 27400 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.02% |
| Oct. 30, 2025 | RA CAPITAL MANAGEMENT, L.P. | Not found | D | Stock Option (Right to Buy) | 45150 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.03% |
| Oct. 30, 2025 | RA CAPITAL MANAGEMENT, L.P. | Not found | D | Stock Option (Right to Buy) | 56400 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.04% |
| Oct. 30, 2025 | Altschuler Steven | Not found | D | Stock Option (Right to Buy) | 7000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.00% |
| Oct. 30, 2025 | Altschuler Steven | Not found | D | Stock Option (Right to Buy) | 12500 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.01% |
| Oct. 30, 2025 | Altschuler Steven | Not found | D | Stock Option (Right to Buy) | 25000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.02% |
| Oct. 30, 2025 | Altschuler Steven | Not found | D | Stock Option (Right to Buy) | 27400 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.02% |
| Oct. 30, 2025 | Altschuler Steven | Not found | D | Stock Option (Right to Buy) | 45150 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.03% |
| Oct. 30, 2025 | McWherter Charles | Not found | D | Stock Option (Right to Buy) | 56400 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.04% |
| Oct. 30, 2025 | Martins Ryan | Chief Financial Officer | A | Common Stock | 35000 | $0.00 | 374,295.0000 | 157,880,203 | 10.32% | 0.02% |
| Oct. 30, 2025 | Martins Ryan | Chief Financial Officer | U | Common Stock | 374295 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.24% |
| Oct. 30, 2025 | Martins Ryan | Chief Financial Officer | D | Stock Option (Right to Buy) | 47500 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.03% |
| Oct. 30, 2025 | Martins Ryan | Chief Financial Officer | D | Stock Option (Right to Buy) | 57500 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.04% |
| Oct. 30, 2025 | Martins Ryan | Chief Financial Officer | D | Stock Option (Right to Buy) | 48102 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.03% |
| Oct. 30, 2025 | Martins Ryan | Chief Financial Officer | D | Stock Option (Right to Buy) | 110000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.07% |
| Oct. 30, 2025 | Martins Ryan | Chief Financial Officer | D | Stock Option (Right to Buy) | 175000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.11% |
| Oct. 30, 2025 | Martins Ryan | Chief Financial Officer | D | Stock Option (Right to Buy) | 300000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.19% |
| Oct. 30, 2025 | Altschuler Steven | Not found | D | Stock Option (Right to Buy) | 40000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.03% |
| Oct. 30, 2025 | Zoth Lota S. | Not found | D | Stock Option (Right to Buy) | 25000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.02% |
| Oct. 30, 2025 | Zoth Lota S. | Not found | D | Stock Option (Right to Buy) | 12500 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.01% |
| Oct. 30, 2025 | Zoth Lota S. | Not found | D | Stock Option (Right to Buy) | 20000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.01% |
| Oct. 30, 2025 | Atkinson Edward Morrow III | Not found | D | Stock Option (Right to Buy) | 56400 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.04% |
| Oct. 30, 2025 | Atkinson Edward Morrow III | Not found | D | Stock Option (Right to Buy) | 45150 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.03% |
| Oct. 30, 2025 | Atkinson Edward Morrow III | Not found | D | Stock Option (Right to Buy) | 27400 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.02% |
| Oct. 30, 2025 | Atkinson Edward Morrow III | Not found | D | Stock Option (Right to Buy) | 20000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.01% |
| Oct. 30, 2025 | Hayden Michael R | Not found | D | Stock Option (Right to Buy) | 56400 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.04% |
| Oct. 30, 2025 | McWherter Charles | Not found | D | Stock Option (Right to Buy) | 67700 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.04% |
| Oct. 30, 2025 | McWherter Charles | Not found | U | Common Stock | 25000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.02% |
| Oct. 30, 2025 | PALEKAR ROHAN | Chief Executive Officer | D | Stock Option (Right to Buy) | 848000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.54% |
| Oct. 30, 2025 | PALEKAR ROHAN | Chief Executive Officer | D | Stock Option (Right to Buy) | 605000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.38% |
| Oct. 30, 2025 | PALEKAR ROHAN | Chief Executive Officer | D | Stock Option (Right to Buy) | 300000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.19% |
| Oct. 30, 2025 | PALEKAR ROHAN | Chief Executive Officer | D | Stock Option (Right to Buy) | 220000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.14% |
| Oct. 30, 2025 | PALEKAR ROHAN | Chief Executive Officer | D | Stock Option (Right to Buy) | 203750 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.13% |
| Oct. 30, 2025 | PALEKAR ROHAN | Chief Executive Officer | D | Stock Option (Right to Buy) | 170000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.11% |
| Oct. 30, 2025 | PALEKAR ROHAN | Chief Executive Officer | D | Stock Option (Right to Buy) | 132242 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.08% |
| Oct. 30, 2025 | PALEKAR ROHAN | Chief Executive Officer | D | Stock Option (Right to Buy) | 120231 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.08% |
| Oct. 30, 2025 | PALEKAR ROHAN | Chief Executive Officer | U | Common Stock | 934273 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.59% |
| Oct. 30, 2025 | PALEKAR ROHAN | Chief Executive Officer | A | Common Stock | 125000 | $0.00 | 934,273.0000 | 157,880,203 | 15.45% | 0.08% |
| Oct. 30, 2025 | Altschuler Steven | Not found | D | Stock Option (Right to Buy) | 56400 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.04% |
| Oct. 30, 2025 | LAPORTE KATHLEEN | Not found | D | Stock Option (Right to Buy) | 25000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.02% |
| Oct. 30, 2025 | LAPORTE KATHLEEN | Not found | D | Stock Option (Right to Buy) | 12500 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.01% |
| Oct. 30, 2025 | LAPORTE KATHLEEN | Not found | D | Stock Option (Right to Buy) | 27400 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.02% |
| Oct. 30, 2025 | LAPORTE KATHLEEN | Not found | D | Stock Option (Right to Buy) | 45150 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.03% |
| Oct. 30, 2025 | LAPORTE KATHLEEN | Not found | D | Stock Option (Right to Buy) | 56400 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.04% |
| Oct. 30, 2025 | Hayden Michael R | Not found | U | Common Stock | 80904 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.05% |
| Oct. 30, 2025 | Hayden Michael R | Not found | U | Common Stock | 103978 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.07% |
| Oct. 30, 2025 | Hayden Michael R | Not found | U | Common Stock | 61538 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.04% |
| Oct. 30, 2025 | Hayden Michael R | Not found | D | Stock Option (Right to Buy) | 27647 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.02% |
| Oct. 30, 2025 | Hayden Michael R | Not found | D | Stock Option (Right to Buy) | 2933 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.00% |
| Oct. 30, 2025 | Hayden Michael R | Not found | D | Stock Option (Right to Buy) | 22730 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.01% |
| Oct. 30, 2025 | Hayden Michael R | Not found | D | Stock Option (Right to Buy) | 7000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.00% |
| Oct. 30, 2025 | Hayden Michael R | Not found | D | Stock Option (Right to Buy) | 7000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.00% |
| Oct. 30, 2025 | Hayden Michael R | Not found | D | Stock Option (Right to Buy) | 12500 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.01% |
| Oct. 30, 2025 | Hayden Michael R | Not found | D | Stock Option (Right to Buy) | 25000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.02% |
| Oct. 30, 2025 | Hayden Michael R | Not found | D | Stock Option (Right to Buy) | 27400 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.02% |
| Oct. 30, 2025 | Hayden Michael R | Not found | D | Stock Option (Right to Buy) | 45150 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.03% |
| Oct. 30, 2025 | Mansbach Harry H | Chief Medical Officer | D | Stock Option (Right to Buy) | 320000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.20% |
| Oct. 30, 2025 | Mansbach Harry H | Chief Medical Officer | D | Stock Option (Right to Buy) | 195000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.12% |
| Oct. 30, 2025 | Mansbach Harry H | Chief Medical Officer | D | Stock Option (Right to Buy) | 120000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.08% |
| Oct. 30, 2025 | Mansbach Harry H | Chief Medical Officer | D | Stock Option (Right to Buy) | 70000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.04% |
| Oct. 30, 2025 | Mansbach Harry H | Chief Medical Officer | D | Stock Option (Right to Buy) | 67500 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.04% |
| Oct. 30, 2025 | Mansbach Harry H | Chief Medical Officer | D | Stock Option (Right to Buy) | 45000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.03% |
| Oct. 30, 2025 | Mansbach Harry H | Chief Medical Officer | D | Stock Option (Right to Buy) | 39037 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.02% |
| Oct. 30, 2025 | Mansbach Harry H | Chief Medical Officer | D | Stock Option (Right to Buy) | 98204 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.06% |
| Oct. 30, 2025 | Mansbach Harry H | Chief Medical Officer | U | Common Stock | 352656 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.22% |
| Oct. 30, 2025 | Mansbach Harry H | Chief Medical Officer | A | Common Stock | 50000 | $0.00 | 352,656.0000 | 157,880,203 | 16.52% | 0.03% |
| Oct. 30, 2025 | Sarena Francis Willard | Chief Operating Officer | D | Stock Option (Right to Buy) | 215000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.14% |
| Oct. 30, 2025 | Sarena Francis Willard | Chief Operating Officer | D | Stock Option (Right to Buy) | 350000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.22% |
| Oct. 30, 2025 | Sarena Francis Willard | Chief Operating Officer | U | Common Stock | 75310 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.05% |
| Oct. 30, 2025 | DiRocco Derek | Not found | D | Stock Option (Right to Buy) | 56400 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.04% |
| Oct. 30, 2025 | DiRocco Derek | Not found | D | Stock Option (Right to Buy) | 45150 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.03% |
| Oct. 30, 2025 | DiRocco Derek | Not found | D | Stock Option (Right to Buy) | 27400 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.02% |
| Oct. 30, 2025 | DiRocco Derek | Not found | D | Stock Option (Right to Buy) | 25000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.02% |
| Oct. 30, 2025 | DiRocco Derek | Not found | D | Stock Option (Right to Buy) | 12500 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.01% |
| Oct. 30, 2025 | DiRocco Derek | Not found | D | Stock Option (Right to Buy) | 7000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.00% |
| Oct. 30, 2025 | DiRocco Derek | Not found | D | Stock Option (Right to Buy) | 7000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.00% |
| Oct. 30, 2025 | Babler Martin | Not found | D | Stock Option (Right to Buy) | 56400 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.04% |
| Oct. 30, 2025 | Babler Martin | Not found | D | Stock Option (Right to Buy) | 67700 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.04% |
| Oct. 30, 2025 | Le-Nguyen Quoc | See Remarks | D | Stock Option (Right to Buy) | 17500 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.01% |
| Oct. 30, 2025 | Le-Nguyen Quoc | See Remarks | D | Stock Option (Right to Buy) | 26400 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.02% |
| Oct. 30, 2025 | Le-Nguyen Quoc | See Remarks | D | Stock Option (Right to Buy) | 320000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.20% |
| Oct. 30, 2025 | Le-Nguyen Quoc | See Remarks | D | Stock Option (Right to Buy) | 195000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.12% |
| Oct. 30, 2025 | Le-Nguyen Quoc | See Remarks | D | Stock Option (Right to Buy) | 120000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.08% |
| Oct. 30, 2025 | Le-Nguyen Quoc | See Remarks | D | Stock Option (Right to Buy) | 70000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.04% |
| Oct. 30, 2025 | Le-Nguyen Quoc | See Remarks | D | Stock Option (Right to Buy) | 67500 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.04% |
| Oct. 30, 2025 | Le-Nguyen Quoc | See Remarks | D | Stock Option (Right to Buy) | 50000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.03% |
| Oct. 30, 2025 | Le-Nguyen Quoc | See Remarks | D | Stock Option (Right to Buy) | 3312 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.00% |
| Oct. 30, 2025 | Le-Nguyen Quoc | See Remarks | D | Stock Option (Right to Buy) | 4063 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.00% |
| Oct. 30, 2025 | Le-Nguyen Quoc | See Remarks | U | Common Stock | 13694 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.01% |
| Oct. 30, 2025 | Le-Nguyen Quoc | See Remarks | U | Common Stock | 351684 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.22% |
| Oct. 30, 2025 | Le-Nguyen Quoc | See Remarks | A | Common Stock | 50000 | $0.00 | 351,684.0000 | 157,880,203 | 16.57% | 0.03% |
| Oct. 30, 2025 | Zoth Lota S. | Not found | D | Stock Option (Right to Buy) | 56400 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.04% |
| Oct. 30, 2025 | Zoth Lota S. | Not found | D | Stock Option (Right to Buy) | 45150 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.03% |
| Oct. 30, 2025 | Zoth Lota S. | Not found | D | Stock Option (Right to Buy) | 27400 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.02% |
| Oct. 22, 2025 | Martins Ryan | Chief Financial Officer | M | Common Stock | 3898 | $4.44 | 339,295.0000 | 157,880,203 | 1.16% | 0.00% |
| Oct. 22, 2025 | Martins Ryan | Chief Financial Officer | M | Common Stock | 76901 | $3.11 | 335,397.0000 | 157,880,203 | 29.75% | 0.05% |
| Oct. 22, 2025 | Martins Ryan | Chief Financial Officer | M | Stock Option (Right to Buy) | 3898 | $0.00 | 48,102.0000 | 157,880,203 | 7.50% | 0.00% |
| Oct. 22, 2025 | Martins Ryan | Chief Financial Officer | M | Stock Option (Right to Buy) | 76901 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.05% |
| Aug. 1, 2025 | Martins Ryan | Chief Financial Officer | F | Common Stock | 7680 | $9.16 | 253,496.0000 | 157,880,203 | 2.94% | 0.00% |
| Aug. 1, 2025 | Sarena Francis Willard | Chief Operating Officer | F | Common Stock | 3206 | $9.16 | 77,210.0000 | 157,880,203 | 3.99% | 0.00% |
| Aug. 1, 2025 | PALEKAR ROHAN | Chief Executive Officer | F | Common Stock | 55836 | $9.16 | 808,070.0000 | 157,880,203 | 6.46% | 0.04% |
| Aug. 1, 2025 | Le-Nguyen Quoc | See Remarks | F | Common Stock | 7680 | $9.16 | 315,378.0000 | 157,880,203 | 2.38% | 0.00% |
| Aug. 5, 2025 | Sarena Francis Willard | Chief Operating Officer | F | Common Stock | 2979 | $9.69 | 74,231.0000 | 157,880,203 | 3.86% | 0.00% |
| Aug. 1, 2025 | Le-Nguyen Quoc | See Remarks | F | Common Stock | 522 | $9.16 | 315,378.0000 | 157,880,203 | 0.17% | 0.00% |
| Aug. 1, 2025 | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 7680 | $9.16 | 302,656.0000 | 157,880,203 | 2.47% | 0.00% |
| July 15, 2025 | Le-Nguyen Quoc | See Remarks | S | Common Stock | 10461 | $11.02 | 323,580.0000 | 157,880,203 | 3.13% | 0.01% |
| June 12, 2025 | Le-Nguyen Quoc | See Remarks | F | Common Stock | 8498 | $9.62 | 334,041.0000 | 104,714,613 | 2.48% | 0.01% |
| June 12, 2025 | Martins Ryan | Chief Financial Officer | F | Common Stock | 8498 | $9.62 | 261,176.0000 | 104,714,613 | 3.15% | 0.01% |
| June 12, 2025 | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 8498 | $9.62 | 310,336.0000 | 104,714,613 | 2.67% | 0.01% |
| June 12, 2025 | Le-Nguyen Quoc | See Remarks | F | Common Stock | 534 | $9.62 | 334,041.0000 | 104,714,613 | 0.16% | 0.00% |
| April 15, 2025 | Le-Nguyen Quoc | See Remarks | S | Common Stock | 15329 | $5.95 | 343,073.0000 | 104,714,613 | 4.28% | 0.01% |
| Feb. 17, 2025 | PALEKAR ROHAN | Chief Executive Officer | F | Common Stock | 3249 | $10.57 | 862,240.0000 | 104,714,613 | 0.38% | 0.00% |
| Feb. 1, 2025 | Le-Nguyen Quoc | See Remarks | A | Stock Option (Right to Buy) | 17500 | $0.00 | 17,500.0000 | 104,714,613 | 9999.99% | 0.02% |
| April 2, 2024 | Le-Nguyen Quoc | See Remarks | A | Stock Option (Right to Buy) | 26400 | $0.00 | 26,400.0000 | 71,172,870 | 9999.99% | 0.04% |
| Feb. 17, 2025 | Le-Nguyen Quoc | See Remarks | F | Common Stock | 1050 | $10.57 | 358,402.0000 | 104,714,613 | 0.29% | 0.00% |
| Dec. 12, 2024 | Le-Nguyen Quoc | See Remarks | A | Common Stock | 6000 | $0.00 | 349,652.0000 | 99,831,111 | 1.75% | 0.01% |
| Feb. 1, 2025 | Le-Nguyen Quoc | See Remarks | A | Common Stock | 8750 | $9.60 | 358,402.0000 | 104,714,613 | 2.50% | 0.01% |
| Feb. 17, 2025 | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 1050 | $10.57 | 318,834.0000 | 104,714,613 | 0.33% | 0.00% |
| Feb. 17, 2025 | Martins Ryan | Chief Financial Officer | F | Common Stock | 780 | $10.57 | 269,674.0000 | 104,714,613 | 0.29% | 0.00% |
| Feb. 9, 2025 | Le-Nguyen Quoc | See Remarks | F | Common Stock | 3793 | $11.41 | 344,702.0000 | 104,714,613 | 1.09% | 0.00% |
| Feb. 9, 2025 | Martins Ryan | Chief Financial Officer | F | Common Stock | 3828 | $11.41 | 270,454.0000 | 104,714,613 | 1.40% | 0.00% |
| Feb. 9, 2025 | PALEKAR ROHAN | Chief Executive Officer | F | Common Stock | 8946 | $11.41 | 864,692.0000 | 104,714,613 | 1.02% | 0.01% |
| Feb. 9, 2025 | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 3817 | $11.41 | 319,884.0000 | 104,714,613 | 1.18% | 0.00% |
| Feb. 3, 2025 | Hayden Michael R | Not found | A | Stock Option (Right to Buy) | 56400 | $0.00 | 56,400.0000 | 104,714,613 | 9999.99% | 0.05% |
| Feb. 3, 2025 | Babler Martin | Not found | A | Stock Option (Right to Buy) | 56400 | $0.00 | 56,400.0000 | 104,714,613 | 9999.99% | 0.05% |
| Feb. 3, 2025 | Zoth Lota S. | Not found | A | Stock Option (Right to Buy) | 56400 | $0.00 | 56,400.0000 | 104,714,613 | 9999.99% | 0.05% |
| Feb. 3, 2025 | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 56400 | $0.00 | 56,400.0000 | 104,714,613 | 9999.99% | 0.05% |
| Feb. 3, 2025 | DiRocco Derek | Not found | A | Stock Option (Right to Buy) | 56400 | $0.00 | 56,400.0000 | 104,714,613 | 9999.99% | 0.05% |
| Feb. 3, 2025 | Altschuler Steven | Not found | A | Stock Option (Right to Buy) | 56400 | $0.00 | 56,400.0000 | 104,714,613 | 9999.99% | 0.05% |
| Feb. 3, 2025 | McWherter Charles | Not found | A | Stock Option (Right to Buy) | 56400 | $0.00 | 56,400.0000 | 104,714,613 | 9999.99% | 0.05% |
| Feb. 3, 2025 | Atkinson Edward Morrow III | Not found | A | Stock Option (Right to Buy) | 56400 | $0.00 | 56,400.0000 | 104,714,613 | 9999.99% | 0.05% |
| Feb. 3, 2025 | LAPORTE KATHLEEN | Not found | A | Stock Option (Right to Buy) | 56400 | $0.00 | 56,400.0000 | 104,714,613 | 9999.99% | 0.05% |
| Feb. 1, 2025 | Le-Nguyen Quoc | See Remarks | A | Stock Option (Right to Buy) | 320000 | $0.00 | 320,000.0000 | 104,714,613 | 9999.99% | 0.31% |
| Feb. 1, 2025 | Martins Ryan | Chief Financial Officer | A | Common Stock | 80000 | $0.00 | 277,620.0000 | 104,714,613 | 40.48% | 0.08% |
| Feb. 1, 2025 | Martins Ryan | Chief Financial Officer | F | Common Stock | 3338 | $9.60 | 274,282.0000 | 104,714,613 | 1.20% | 0.00% |
| Feb. 1, 2025 | Martins Ryan | Chief Financial Officer | A | Stock Option (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 104,714,613 | 9999.99% | 0.29% |
| Feb. 1, 2025 | Le-Nguyen Quoc | See Remarks | A | Common Stock | 80000 | $0.00 | 351,833.0000 | 104,714,613 | 29.43% | 0.08% |
| Feb. 1, 2025 | Le-Nguyen Quoc | See Remarks | F | Common Stock | 3338 | $9.60 | 348,495.0000 | 104,714,613 | 0.95% | 0.00% |
| Feb. 1, 2025 | PALEKAR ROHAN | Chief Executive Officer | A | Common Stock | 212000 | $0.00 | 683,236.0000 | 104,714,613 | 44.99% | 0.20% |
| Feb. 1, 2025 | PALEKAR ROHAN | Chief Executive Officer | A | Common Stock | 200000 | $0.00 | 883,236.0000 | 104,714,613 | 29.27% | 0.19% |
| Feb. 1, 2025 | PALEKAR ROHAN | Chief Executive Officer | F | Common Stock | 9598 | $9.60 | 873,638.0000 | 104,714,613 | 1.09% | 0.01% |
| Feb. 1, 2025 | PALEKAR ROHAN | Chief Executive Officer | A | Stock Option (Right to Buy) | 848000 | $0.00 | 848,000.0000 | 104,714,613 | 9999.99% | 0.81% |
| Feb. 1, 2025 | Mansbach Harry H | Chief Medical Officer | A | Common Stock | 80000 | $0.00 | 327,039.0000 | 104,714,613 | 32.38% | 0.08% |
| Feb. 1, 2025 | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 3338 | $9.60 | 323,701.0000 | 104,714,613 | 1.02% | 0.00% |
| Feb. 1, 2025 | Mansbach Harry H | Chief Medical Officer | A | Stock Option (Right to Buy) | 320000 | $0.00 | 320,000.0000 | 104,714,613 | 9999.99% | 0.31% |
| Feb. 1, 2025 | Sarena Francis Willard | Chief Operating Officer | A | Common Stock | 53750 | $0.00 | 78,750.0000 | 104,714,613 | 215.00% | 0.05% |
| Feb. 1, 2025 | Sarena Francis Willard | Chief Operating Officer | A | Stock Option (Right to Buy) | 215000 | $0.00 | 215,000.0000 | 104,714,613 | 9999.99% | 0.21% |
| Jan. 30, 2025 | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 5714285 | $8.75 | 19,889,683.0000 | 104,714,613 | 40.31% | 5.46% |
| Jan. 21, 2025 | McWherter Charles | Not found | P | Common Stock | 5000 | $6.55 | 15,000.0000 | 104,714,613 | 50.00% | 0.00% |
| Jan. 22, 2025 | McWherter Charles | Not found | P | Common Stock | 10000 | $6.71 | 25,000.0000 | 104,714,613 | 66.67% | 0.01% |
| Jan. 15, 2025 | Le-Nguyen Quoc | See Remarks | S | Common Stock | 10963 | $6.49 | 271,833.0000 | 104,714,613 | 3.88% | 0.01% |
| Dec. 12, 2024 | Martins Ryan | Chief Financial Officer | A | Common Stock | 95000 | $0.00 | 197,620.0000 | 99,831,111 | 32.47% | 0.10% |
| Dec. 12, 2024 | Mansbach Harry H | Chief Medical Officer | A | Common Stock | 95000 | $0.00 | 247,039.0000 | 99,831,111 | 27.77% | 0.10% |
| Dec. 12, 2024 | Le-Nguyen Quoc | See Remarks | A | Common Stock | 95000 | $0.00 | 282,796.0000 | 99,831,111 | 25.15% | 0.10% |
| Dec. 6, 2024 | PALEKAR ROHAN | Chief Executive Officer | P | Common Stock | 5000 | $7.89 | 471,236.0000 | 99,831,111 | 1.07% | 0.01% |
| Dec. 5, 2024 | McWherter Charles | Not found | P | Common Stock | 10000 | $8.00 | 10,000.0000 | 99,831,111 | 9999.99% | 0.01% |
| Nov. 22, 2024 | PALEKAR ROHAN | Chief Executive Officer | P | Common Stock | 10000 | $8.35 | 466,236.0000 | 99,831,111 | 2.19% | 0.01% |
| Nov. 14, 2024 | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Pre-Funded Warrants (Right to Buy) | 3250000 | $8.50 | 4,331,081.0000 | 99,831,111 | 300.63% | 3.26% |
| Oct. 30, 2024 | Le-Nguyen Quoc | See Remarks | S | Common Stock | 27955 | $8.12 | 187,796.0000 | 99,831,111 | 12.96% | 0.03% |
| Sept. 9, 2024 | Martins Ryan | Chief Financial Officer | F | Common Stock | 3212 | $8.46 | 102,620.0000 | 99,831,111 | 3.03% | 0.00% |
| Sept. 9, 2024 | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 5352 | $8.46 | 152,039.0000 | 99,831,111 | 3.40% | 0.01% |
| Sept. 9, 2024 | Le-Nguyen Quoc | See Remarks | F | Common Stock | 5352 | $8.46 | 215,751.0000 | 99,831,111 | 2.42% | 0.01% |
| Aug. 17, 2024 | Martins Ryan | Chief Financial Officer | F | Common Stock | 777 | $8.04 | 105,832.0000 | 99,831,111 | 0.73% | 0.00% |
| Aug. 17, 2024 | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 1046 | $8.04 | 157,391.0000 | 99,831,111 | 0.66% | 0.00% |
| Aug. 17, 2024 | PALEKAR ROHAN | Chief Executive Officer | F | Common Stock | 4601 | $8.04 | 456,236.0000 | 99,831,111 | 1.00% | 0.00% |
| Aug. 17, 2024 | Le-Nguyen Quoc | See Remarks | F | Common Stock | 1046 | $8.04 | 221,103.0000 | 99,831,111 | 0.47% | 0.00% |
| Aug. 5, 2024 | Sarena Francis Willard | Chief Operating Officer | A | Stock Option (Right to Buy) | 350000 | $0.00 | 350,000.0000 | 99,831,111 | 9999.99% | 0.35% |
| Aug. 5, 2024 | McWherter Charles | Not found | A | Stock Option (Right to Buy) | 67700 | $0.00 | 67,700.0000 | 99,831,111 | 9999.99% | 0.07% |
| Aug. 5, 2024 | Sarena Francis Willard | Chief Operating Officer | A | Common Stock | 25000 | $0.00 | 25,000.0000 | 99,831,111 | 9999.99% | 0.03% |
| May 2, 2024 | Babler Martin | Not found | A | Stock Option (Right to Buy) | 67700 | $0.00 | 67,700.0000 | 71,172,870 | 9999.99% | 0.10% |
| Feb. 1, 2024 | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 45150 | $0.00 | 45,150.0000 | 71,172,870 | 9999.99% | 0.06% |
| April 11, 2024 | RA CAPITAL MANAGEMENT, L.P. | Not found | X | Common Stock | 1408450 | $5.33 | 14,175,398.0000 | 71,172,870 | 11.03% | 1.98% |
| Feb. 9, 2023 | RA CAPITAL MANAGEMENT, L.P. | Not found | A | Stock Option (Right to Buy) | 27400 | $0.00 | 27,400.0000 | 34,806,349 | 9999.99% | 0.08% |
| April 11, 2024 | RA CAPITAL MANAGEMENT, L.P. | Not found | X | Warrants (Right to Buy) | 2816900 | $0.00 | 0.0000 | 71,172,870 | 100.00% | 3.96% |
| April 1, 2024 | PALEKAR ROHAN | Chief Executive Officer | S | Common Stock | 52718 | $10.91 | 459,171.0000 | 71,172,870 | 10.30% | 0.07% |
| April 1, 2024 | PALEKAR ROHAN | Chief Executive Officer | M | Common Stock | 25000 | $1.93 | 511,889.0000 | 71,172,870 | 5.13% | 0.04% |
| April 1, 2024 | PALEKAR ROHAN | Chief Executive Officer | M | Stock Option (Right to Buy) | 25000 | $0.00 | 120,231.0000 | 71,172,870 | 17.21% | 0.04% |
| March 4, 2024 | RA CAPITAL MANAGEMENT, L.P. | Not found | P | Common Stock | 1350000 | $15.35 | 12,766,948.0000 | 71,172,870 | 11.82% | 1.90% |
| Feb. 26, 2024 | PALEKAR ROHAN | Chief Executive Officer | S | Common Stock | 4477 | $10.76 | 486,889.0000 | 71,172,870 | 0.91% | 0.01% |
| Feb. 17, 2024 | Martins Ryan | Chief Financial Officer | F | Common Stock | 778 | $9.74 | 106,609.0000 | 71,172,870 | 0.72% | 0.00% |
| Feb. 17, 2024 | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 1046 | $9.74 | 158,437.0000 | 71,172,870 | 0.66% | 0.00% |
| Feb. 17, 2024 | Le-Nguyen Quoc | See Remarks | F | Common Stock | 1046 | $9.74 | 222,149.0000 | 71,172,870 | 0.47% | 0.00% |
| Feb. 17, 2024 | PALEKAR ROHAN | Chief Executive Officer | F | Common Stock | 4602 | $9.74 | 491,366.0000 | 71,172,870 | 0.93% | 0.01% |
| Feb. 9, 2024 | Le-Nguyen Quoc | See Remarks | F | Common Stock | 3568 | $8.45 | 223,195.0000 | 71,172,870 | 1.57% | 0.01% |
| Feb. 9, 2024 | PALEKAR ROHAN | Chief Executive Officer | F | Common Stock | 12670 | $8.45 | 480,968.0000 | 71,172,870 | 2.57% | 0.02% |
| Feb. 9, 2024 | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 3568 | $8.45 | 159,483.0000 | 71,172,870 | 2.19% | 0.01% |
| Feb. 9, 2024 | Martins Ryan | Chief Financial Officer | F | Common Stock | 3568 | $8.45 | 107,387.0000 | 71,172,870 | 3.22% | 0.01% |
| Feb. 1, 2024 | Le-Nguyen Quoc | See Remarks | A | Common Stock | 48750 | $0.00 | 227,953.0000 | 71,172,870 | 27.20% | 0.07% |
| Feb. 5, 2024 | Le-Nguyen Quoc | See Remarks | F | Common Stock | 1190 | $9.80 | 226,763.0000 | 71,172,870 | 0.52% | 0.00% |
| Feb. 1, 2024 | Le-Nguyen Quoc | See Remarks | A | Stock Option (Right to Buy) | 195000 | $0.00 | 195,000.0000 | 71,172,870 | 9999.99% | 0.27% |
| Feb. 1, 2024 | Hayden Michael R | Not found | A | Stock Option (Right to Buy) | 45150 | $0.00 | 45,150.0000 | 71,172,870 | 9999.99% | 0.06% |
| Feb. 1, 2024 | DiRocco Derek | Not found | A | Stock Option (Right to Buy) | 45150 | $0.00 | 45,150.0000 | 71,172,870 | 9999.99% | 0.06% |
| Feb. 1, 2024 | PALEKAR ROHAN | Chief Executive Officer | A | Common Stock | 150000 | $0.00 | 498,714.0000 | 71,172,870 | 43.02% | 0.21% |
| Feb. 5, 2024 | PALEKAR ROHAN | Chief Executive Officer | F | Common Stock | 5068 | $9.80 | 493,646.0000 | 71,172,870 | 1.02% | 0.01% |
| Feb. 1, 2024 | PALEKAR ROHAN | Chief Executive Officer | A | Stock Option (Right to Buy) | 605000 | $0.00 | 605,000.0000 | 71,172,870 | 9999.99% | 0.85% |
| Feb. 1, 2024 | Atkinson Edward Morrow III | Not found | A | Stock Option (Right to Buy) | 45150 | $0.00 | 45,150.0000 | 71,172,870 | 9999.99% | 0.06% |
| Feb. 1, 2024 | LAPORTE KATHLEEN | Not found | A | Stock Option (Right to Buy) | 45150 | $0.00 | 45,150.0000 | 71,172,870 | 9999.99% | 0.06% |
| Feb. 1, 2024 | Altschuler Steven | Not found | A | Stock Option (Right to Buy) | 45150 | $0.00 | 45,150.0000 | 71,172,870 | 9999.99% | 0.06% |
| Feb. 1, 2024 | Zoth Lota S. | Not found | A | Stock Option (Right to Buy) | 45150 | $0.00 | 45,150.0000 | 71,172,870 | 9999.99% | 0.06% |
| Feb. 1, 2024 | Martins Ryan | Chief Financial Officer | A | Common Stock | 48750 | $0.00 | 111,847.0000 | 71,172,870 | 77.26% | 0.07% |
| Feb. 1, 2024 | Martins Ryan | Chief Financial Officer | A | Stock Option (Right to Buy) | 175000 | $0.00 | 175,000.0000 | 71,172,870 | 9999.99% | 0.25% |
| Feb. 5, 2024 | Martins Ryan | Chief Financial Officer | F | Common Stock | 892 | $9.80 | 110,955.0000 | 71,172,870 | 0.80% | 0.00% |
| Feb. 1, 2024 | Mansbach Harry H | Chief Medical Officer | A | Common Stock | 48750 | $0.00 | 164,241.0000 | 71,172,870 | 42.21% | 0.07% |
| Feb. 5, 2024 | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 1190 | $9.80 | 163,051.0000 | 71,172,870 | 0.72% | 0.00% |
| Feb. 1, 2024 | Mansbach Harry H | Chief Medical Officer | A | Stock Option (Right to Buy) | 195000 | $0.00 | 195,000.0000 | 71,172,870 | 9999.99% | 0.27% |
| Jan. 5, 2024 | Le-Nguyen Quoc | See Remarks | F | Common Stock | 9671 | $11.53 | 179,203.0000 | 71,172,870 | 5.12% | 0.01% |
| Jan. 5, 2024 | PALEKAR ROHAN | Chief Executive Officer | F | Common Stock | 27511 | $11.53 | 348,714.0000 | 71,172,870 | 7.31% | 0.04% |
| Jan. 5, 2024 | Mansbach Harry H | Chief Medical Officer | A | Common Stock | 25000 | $0.00 | 125,162.0000 | 71,172,870 | 24.96% | 0.04% |
| Jan. 5, 2024 | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 9671 | $11.53 | 115,491.0000 | 71,172,870 | 7.73% | 0.01% |
| Jan. 5, 2024 | Martins Ryan | Chief Financial Officer | A | Common Stock | 15000 | $0.00 | 69,221.0000 | 71,172,870 | 27.66% | 0.02% |
| Jan. 5, 2024 | Martins Ryan | Chief Financial Officer | F | Common Stock | 6124 | $11.53 | 63,097.0000 | 71,172,870 | 8.85% | 0.01% |
| Jan. 5, 2024 | Le-Nguyen Quoc | See Remarks | A | Common Stock | 25000 | $0.00 | 188,874.0000 | 71,172,870 | 15.26% | 0.04% |
| Jan. 5, 2024 | PALEKAR ROHAN | Chief Executive Officer | A | Common Stock | 75000 | $0.00 | 376,225.0000 | 71,172,870 | 24.90% | 0.11% |
| Dec. 29, 2023 | PALEKAR ROHAN | Chief Executive Officer | S | Common Stock | 50000 | $11.20 | 301,225.0000 | 34,806,349 | 14.24% | 0.14% |
| Dec. 29, 2023 | PALEKAR ROHAN | Chief Executive Officer | M | Stock Option (Right to Buy) | 50000 | $0.00 | 145,231.0000 | 34,806,349 | 25.61% | 0.14% |
| Dec. 29, 2023 | PALEKAR ROHAN | Chief Executive Officer | M | Common Stock | 50000 | $1.93 | 351,225.0000 | 34,806,349 | 16.60% | 0.14% |
| Dec. 11, 2023 | RA CAPITAL MANAGEMENT, L.P. | Director | P | Pre-Funded Warrants (Right to Buy) | 1081081 | $9.25 | 1,081,081.0000 | 34,806,349 | 9999.99% | 3.11% |
| Sept. 9, 2023 | Martins Ryan | Chief Financial Officer | F | Common Stock | 2074 | $16.61 | 54,221.0000 | 34,806,349 | 3.68% | 0.01% |
| Sept. 9, 2023 | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 3821 | $16.61 | 100,162.0000 | 34,806,349 | 3.67% | 0.01% |
| Sept. 9, 2023 | Le-Nguyen Quoc | See Remarks | F | Common Stock | 4958 | $16.61 | 163,874.0000 | 34,806,349 | 2.94% | 0.01% |
| Aug. 1, 2023 | Le-Nguyen Quoc | See Remarks | F | Common Stock | 1014 | $15.46 | 168,832.0000 | 34,806,349 | 0.60% | 0.00% |
| Aug. 1, 2023 | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 577 | $15.64 | 104,997.0000 | 34,806,349 | 0.55% | 0.00% |
| Aug. 17, 2023 | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 1014 | $15.46 | 103,983.0000 | 34,806,349 | 0.97% | 0.00% |
| Aug. 17, 2023 | PALEKAR ROHAN | Chief Executive Officer | F | Common Stock | 4501 | $15.46 | 300,950.0000 | 34,806,349 | 1.47% | 0.01% |
| Aug. 1, 2023 | Martins Ryan | Chief Financial Officer | F | Common Stock | 346 | $15.64 | 57,048.0000 | 34,806,349 | 0.60% | 0.00% |
| Aug. 17, 2023 | Martins Ryan | Chief Financial Officer | F | Common Stock | 753 | $15.46 | 56,295.0000 | 34,806,349 | 1.32% | 0.00% |
| Aug. 1, 2023 | Le-Nguyen Quoc | See Remarks | F | Common Stock | 577 | $15.64 | 169,846.0000 | 34,806,349 | 0.34% | 0.00% |
| July 17, 2023 | LAPORTE KATHLEEN | Not found | M | Common Stock | 12500 | $2.64 | 12,500.0000 | 34,806,349 | 9999.99% | 0.04% |
| July 17, 2023 | LAPORTE KATHLEEN | Not found | S | Common Stock | 12500 | $18.80 | 0.0000 | 34,806,349 | 100.00% | 0.04% |
| July 17, 2023 | LAPORTE KATHLEEN | Not found | M | Stock Option (Right to Buy) | 12500 | $0.00 | 12,500.0000 | 34,806,349 | 50.00% | 0.04% |
| June 30, 2023 | Mansbach Harry H | Chief Medical Officer | A | Common Stock | 8334 | $0.00 | 108,456.0000 | 34,806,349 | 8.32% | 0.02% |
| June 30, 2023 | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 2882 | $18.95 | 105,574.0000 | 34,806,349 | 2.66% | 0.01% |
| June 30, 2023 | Le-Nguyen Quoc | See Remarks | A | Common Stock | 8334 | $0.00 | 173,305.0000 | 34,806,349 | 5.05% | 0.02% |
| June 30, 2023 | Le-Nguyen Quoc | See Remarks | F | Common Stock | 2882 | $18.95 | 170,423.0000 | 34,806,349 | 1.66% | 0.01% |
| June 30, 2023 | PALEKAR ROHAN | Chief Executive Officer | A | Common Stock | 33334 | $0.00 | 321,978.0000 | 34,806,349 | 11.55% | 0.10% |
| June 30, 2023 | PALEKAR ROHAN | Chief Executive Officer | F | Common Stock | 16527 | $18.95 | 305,451.0000 | 34,806,349 | 5.13% | 0.05% |
| June 30, 2023 | Martins Ryan | Chief Financial Officer | A | Common Stock | 5834 | $0.00 | 59,412.0000 | 34,806,349 | 10.89% | 0.02% |
| June 30, 2023 | Martins Ryan | Chief Financial Officer | F | Common Stock | 2018 | $18.95 | 57,394.0000 | 34,806,349 | 3.40% | 0.01% |
| June 5, 2023 | PALEKAR ROHAN | Chief Executive Officer | M | Common Stock | 15000 | $1.93 | 301,978.0000 | 34,806,349 | 5.23% | 0.04% |
| June 5, 2023 | PALEKAR ROHAN | Chief Executive Officer | S | Common Stock | 15000 | $20.00 | 286,978.0000 | 34,806,349 | 4.97% | 0.04% |
| June 5, 2023 | PALEKAR ROHAN | Chief Executive Officer | M | Stock Option (Right to Buy) | 15000 | $0.00 | 195,231.0000 | 34,806,349 | 7.14% | 0.04% |
| June 1, 2023 | Atkinson Edward Morrow III | Not found | M | Common Stock | 6250 | $2.61 | 6,250.0000 | 34,806,349 | 9999.99% | 0.02% |
| June 1, 2023 | Atkinson Edward Morrow III | Not found | S | Common Stock | 6250 | $17.91 | 0.0000 | 34,806,349 | 100.00% | 0.02% |
| June 1, 2023 | Atkinson Edward Morrow III | Not found | M | Stock Option (Right to Buy) | 6250 | $0.00 | 0.0000 | 34,806,349 | 100.00% | 0.02% |
| May 9, 2023 | Le-Nguyen Quoc | See Remarks | M | Common Stock | 60945 | $3.11 | 160,028.0000 | 34,806,349 | 61.51% | 0.18% |
| May 9, 2023 | Le-Nguyen Quoc | See Remarks | M | Common Stock | 18626 | $3.11 | 178,654.0000 | 34,806,349 | 11.64% | 0.05% |
| May 9, 2023 | Le-Nguyen Quoc | See Remarks | S | Common Stock | 13683 | $18.11 | 164,971.0000 | 34,806,349 | 7.66% | 0.04% |
| May 9, 2023 | Le-Nguyen Quoc | See Remarks | M | Stock Option (Right to Buy) | 60945 | $0.00 | 4,063.0000 | 34,806,349 | 93.75% | 0.18% |
| May 9, 2023 | Le-Nguyen Quoc | See Remarks | M | Stock Option (Right to Buy) | 18626 | $0.00 | 3,312.0000 | 34,806,349 | 84.90% | 0.05% |
| April 4, 2023 | Martins Ryan | Chief Financial Officer | S | Common Stock | 8721 | $14.95 | 53,578.0000 | 34,806,349 | 14.00% | 0.03% |
| March 31, 2023 | Martins Ryan | Chief Financial Officer | A | Common Stock | 5833 | $0.00 | 59,411.0000 | 34,806,349 | 10.89% | 0.02% |
| March 31, 2023 | Martins Ryan | Chief Financial Officer | F | Common Stock | 2018 | $15.23 | 57,393.0000 | 34,806,349 | 3.40% | 0.01% |
| March 31, 2023 | Martins Ryan | Chief Financial Officer | A | Common Stock | 7500 | $0.00 | 64,893.0000 | 34,806,349 | 13.07% | 0.02% |
| March 31, 2023 | Martins Ryan | Chief Financial Officer | F | Common Stock | 2594 | $15.23 | 62,299.0000 | 34,806,349 | 4.00% | 0.01% |
| March 31, 2023 | PALEKAR ROHAN | Chief Executive Officer | A | Common Stock | 33333 | $0.00 | 302,413.0000 | 34,806,349 | 12.39% | 0.10% |
| March 31, 2023 | PALEKAR ROHAN | Chief Executive Officer | F | Common Stock | 15443 | $15.23 | 286,970.0000 | 34,806,349 | 5.11% | 0.04% |
| March 31, 2023 | Mansbach Harry H | Chief Medical Officer | A | Common Stock | 8333 | $0.00 | 103,004.0000 | 34,806,349 | 8.80% | 0.02% |
| March 31, 2023 | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 2882 | $15.23 | 100,122.0000 | 34,806,349 | 2.80% | 0.01% |
| March 31, 2023 | Le-Nguyen Quoc | See Remarks | A | Common Stock | 8333 | $0.00 | 99,512.0000 | 34,806,349 | 9.14% | 0.02% |
| March 31, 2023 | Le-Nguyen Quoc | See Remarks | F | Common Stock | 2882 | $15.23 | 96,630.0000 | 34,806,349 | 2.90% | 0.01% |
| March 31, 2023 | Le-Nguyen Quoc | See Remarks | A | Common Stock | 3750 | $0.00 | 100,380.0000 | 34,806,349 | 3.88% | 0.01% |
| March 31, 2023 | Le-Nguyen Quoc | See Remarks | F | Common Stock | 1297 | $15.23 | 99,083.0000 | 34,806,349 | 1.29% | 0.00% |
| March 24, 2023 | RA CAPITAL MANAGEMENT, L.P. | Director | P | Common Stock | 2461538 | $16.25 | 11,416,948.0000 | 34,806,349 | 27.49% | 7.07% |
| March 30, 2022 | Hayden Michael R | Not found | P | Common Stock | 6250 | $3.62 | 164,882.0000 | 0 | 3.94% | 0.00% |
| April 7, 2022 | Hayden Michael R | Not found | P | Common Stock | 10000 | $3.48 | 174,882.0000 | 0 | 6.06% | 0.00% |
| April 25, 2022 | Hayden Michael R | Not found | P | Common Stock | 10000 | $2.67 | 184,882.0000 | 0 | 5.72% | 0.00% |
| March 28, 2023 | Hayden Michael R | Not found | P | Common Stock | 61538 | $16.15 | 142,442.0000 | 34,806,349 | 76.06% | 0.18% |
| March 23, 2023 | Martins Ryan | Chief Financial Officer | S | Common Stock | 5000 | $16.11 | 53,578.0000 | 34,806,349 | 8.54% | 0.01% |
| March 23, 2023 | PALEKAR ROHAN | Chief Executive Officer | S | Common Stock | 15000 | $16.00 | 269,080.0000 | 34,806,349 | 5.28% | 0.04% |
| March 1, 2023 | Atkinson Edward Morrow III | Director | M | Common Stock | 10000 | $4.44 | 10,000.0000 | 34,806,349 | 9999.99% | 0.03% |
| March 1, 2023 | Atkinson Edward Morrow III | Director | S | Common Stock | 10000 | $13.60 | 0.0000 | 34,806,349 | 100.00% | 0.03% |
| March 1, 2023 | Atkinson Edward Morrow III | Director | M | Stock Option (Right to Buy) | 10000 | $0.00 | 20,000.0000 | 34,806,349 | 33.33% | 0.03% |
| Feb. 17, 2023 | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 2127 | $13.97 | 94,671.0000 | 34,806,349 | 2.20% | 0.01% |
| Feb. 17, 2023 | Martins Ryan | Chief Financial Officer | F | Common Stock | 1750 | $13.97 | 61,118.0000 | 34,806,349 | 2.78% | 0.01% |
| Feb. 21, 2023 | Martins Ryan | Chief Financial Officer | S | Common Stock | 2540 | $13.89 | 58,578.0000 | 34,806,349 | 4.16% | 0.01% |
| Feb. 17, 2023 | Le-Nguyen Quoc | See Remarks | F | Common Stock | 2140 | $13.97 | 91,179.0000 | 34,806,349 | 2.29% | 0.01% |
| Feb. 17, 2023 | PALEKAR ROHAN | Chief Executive Officer | F | Common Stock | 6279 | $13.97 | 284,072.0000 | 34,806,349 | 2.16% | 0.02% |
| Feb. 9, 2023 | Altschuler Steven | Director | A | Stock Option (Right to Buy) | 27400 | $0.00 | 27,400.0000 | 34,806,349 | 9999.99% | 0.08% |
| Feb. 9, 2023 | Martins Ryan | Chief Financial Officer | A | Common Stock | 30000 | $0.00 | 62,868.0000 | 34,806,349 | 91.27% | 0.09% |
| Feb. 9, 2023 | Martins Ryan | Chief Financial Officer | A | Stock Option (Right to Buy) | 110000 | $0.00 | 110,000.0000 | 34,806,349 | 9999.99% | 0.32% |
| Feb. 9, 2023 | Mansbach Harry H | Chief Medical Officer | A | Common Stock | 30000 | $0.00 | 96,798.0000 | 34,806,349 | 44.91% | 0.09% |
| Feb. 9, 2023 | Mansbach Harry H | Chief Medical Officer | A | Stock Option (Right to Buy) | 120000 | $0.00 | 120,000.0000 | 34,806,349 | 9999.99% | 0.34% |
| Feb. 9, 2023 | PALEKAR ROHAN | Chief Executive Officer | A | Common Stock | 75000 | $0.00 | 290,351.0000 | 34,806,349 | 34.83% | 0.22% |
| Feb. 9, 2023 | PALEKAR ROHAN | Chief Executive Officer | A | Stock Option (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 34,806,349 | 9999.99% | 0.86% |
| Feb. 9, 2023 | Zoth Lota S. | Director | A | Stock Option (Right to Buy) | 27400 | $0.00 | 27,400.0000 | 34,806,349 | 9999.99% | 0.08% |
| Feb. 9, 2023 | Le-Nguyen Quoc | See Remarks | A | Common Stock | 30000 | $0.00 | 93,319.0000 | 34,806,349 | 47.38% | 0.09% |
| Feb. 9, 2023 | Le-Nguyen Quoc | See Remarks | A | Stock Option (Right to Buy) | 120000 | $0.00 | 120,000.0000 | 34,806,349 | 9999.99% | 0.34% |
| Feb. 9, 2023 | LAPORTE KATHLEEN | Director | A | Stock Option (Right to Buy) | 27400 | $0.00 | 27,400.0000 | 34,806,349 | 9999.99% | 0.08% |
| Feb. 9, 2023 | Grunberg Gregory | Director | A | Stock Option (Right to Buy) | 27400 | $0.00 | 27,400.0000 | 34,806,349 | 9999.99% | 0.08% |
| Feb. 9, 2023 | Hayden Michael R | Director | A | Stock Option (Right to Buy) | 27400 | $0.00 | 27,400.0000 | 34,806,349 | 9999.99% | 0.08% |
| Feb. 9, 2023 | Atkinson Edward Morrow III | Director | A | Stock Option (Right to Buy) | 27400 | $0.00 | 27,400.0000 | 34,806,349 | 9999.99% | 0.08% |
| Feb. 9, 2023 | DiRocco Derek | Director | A | Stock Option (Right to Buy) | 27400 | $0.00 | 27,400.0000 | 34,806,349 | 9999.99% | 0.08% |
| Feb. 8, 2023 | Martins Ryan | Chief Financial Officer | S | Common Stock | 1480 | $14.41 | 32,868.0000 | 34,806,349 | 4.31% | 0.00% |
| Feb. 5, 2023 | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 1360 | $13.24 | 66,798.0000 | 34,806,349 | 2.00% | 0.00% |
| Feb. 5, 2023 | PALEKAR ROHAN | Chief Executive Officer | F | Common Stock | 4078 | $13.24 | 215,351.0000 | 34,806,349 | 1.86% | 0.01% |
| Feb. 3, 2023 | Martins Ryan | Chief Financial Officer | M | Common Stock | 3000 | $3.11 | 38,960.0000 | 34,806,349 | 8.34% | 0.01% |
| Feb. 3, 2023 | Martins Ryan | Chief Financial Officer | S | Common Stock | 3000 | $13.11 | 38,960.0000 | 34,806,349 | 7.15% | 0.01% |
| Feb. 3, 2023 | Martins Ryan | Chief Financial Officer | S | Common Stock | 592 | $12.70 | 35,368.0000 | 34,806,349 | 1.65% | 0.00% |
| Feb. 5, 2023 | Martins Ryan | Chief Financial Officer | F | Common Stock | 592 | $13.24 | 34,348.0000 | 34,806,349 | 1.69% | 0.00% |
| Feb. 3, 2023 | Martins Ryan | Chief Financial Officer | M | Stock Option (Right to Buy) | 3000 | $0.00 | 81,901.0000 | 34,806,349 | 3.53% | 0.01% |
| Feb. 5, 2023 | Le-Nguyen Quoc | See Remarks | F | Common Stock | 1390 | $13.24 | 63,319.0000 | 34,806,349 | 2.15% | 0.00% |
| Feb. 1, 2023 | Martins Ryan | Chief Financial Officer | F | Common Stock | 408 | $12.05 | 35,960.0000 | 34,806,349 | 1.12% | 0.00% |
| Feb. 1, 2023 | Mansbach Harry H | Chief Medical Officer | F | Common Stock | 680 | $12.05 | 68,158.0000 | 34,806,349 | 0.99% | 0.00% |
| Feb. 1, 2023 | Le-Nguyen Quoc | See Remarks | F | Common Stock | 695 | $12.05 | 64,709.0000 | 34,806,349 | 1.06% | 0.00% |
| Jan. 3, 2023 | Martins Ryan | Chief Financial Officer | S | Common Stock | 5947 | $12.51 | 36,368.0000 | 34,806,349 | 14.05% | 0.02% |